Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HAGEMEIJER A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 151 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Amant, F; Debiec-Rychter, M; Schoenmakers, EFPM; Hagemeijer-Hausman, A; Vergote, I
      Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of Pseudo-Meigs' syndrome

      GENES CHROMOSOMES & CANCER
    2. Deblec-Rychter, M; Sciot, R; Pauwels, P; Schoenmakers, E; Dal Cin, P; Hagemeijer, A
      Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors

      GENES CHROMOSOMES & CANCER
    3. Lambert, I; Debiec-Rychter, M; Guelinckx, P; Hagemeijer, A; Sciot, R
      Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomalchanges

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    4. Sciot, R; Debiec-Rychter, M; De Wever, I; Hagemeijer, A
      Angiomyxolipoma shares cytogenetic changes with lipoma, spindle cell/pleomorphic lipoma and myxoma

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    5. Cuneo, A; Bardi, A; Wlodarska, I; Selleslag, D; Roberti, MG; Bigoni, R; Cavazzini, F; De Angeli, C; Tammiso, E; del Senno, L; Cavazzini, P; Hagemeijer, A; Castoldi, G
      A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zoneB cell lymphoma

      LEUKEMIA
    6. Bakkus, MHC; Asosingh, K; Vanderkerken, K; Thielemans, K; Hagemeijer, A; De Raeve, H; Van Camp, B
      Myeloma isotype-switch variants in the murine 5T myeloma model: evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour

      LEUKEMIA
    7. von Bergh, A; Gargallo, P; De Prijck, B; Vranckx, H; Marschalek, R; Larripa, I; Kluin, P; Schuuring, E; Hagemeijer, A
      Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5 ' MLL sequences in chromosome 4

      LEUKEMIA
    8. Giugliano, E; Rege-Cambrin, G; Scaravaglio, P; Serra, A; Wlodarska, I; Emanuel, B; Saglio, G; Hagemeijer, A
      MLL-AF6 fusion resulting from a new three-way translocation t(6;11;7) in apatient with acute myeloid leukemia

      LEUKEMIA
    9. Winnepenninckx, V; De Vos, R; Debiec-Rychter, M; Samson, I; Brys, P; Hagemeijer, A; Sciot, R
      Calcifying/ossifying synovial sarcoma shows t(X;18) with SSX2 involvement and mitochondrial calcifications

      HISTOPATHOLOGY
    10. Debiec-Rychter, M; de Wever, I; Hagemeijer, A; Sciot, R
      Is 4q13 a recurring breakpoint in solitary fibrous tumors?

      CANCER GENETICS AND CYTOGENETICS
    11. Vieira, L; Oliveira, V; Ambrosio, AP; Marques, B; Pereira, AM; Hagemeijer, A; Boavida, MG
      Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2): a four-way variant of t(8;21)

      CANCER GENETICS AND CYTOGENETICS
    12. Dierlamm, J; Stefanova, M; Wlodarska, I; Michaux, L; Hinz, K; Penas, EMM; Maes, B; Hagemeijer, A; De Wolf-Peeters, C; Hossfeld, DK
      Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization

      CANCER GENETICS AND CYTOGENETICS
    13. Guillaume, B; Ameye, G; Dierlamm, J; Verhoef, G; Duhem, C; Ferrant, A; Hagemeijer, A; Verellen-Dumoulin, C; Michaux, L
      Trisomy 16 as the sole anomaly in hematological malignancies: three new cases and a short review

      CANCER GENETICS AND CYTOGENETICS
    14. Debiec-Rychter, M; Van Valckenborgh, I; Van den Broeck, C; Hagemeijer, A; Van de Ven, WJM; Kas, K; Van Damme, B; Voz, ML
      Histologic localization of PLAG1 (pleomorphic adenoma gene 1) in pleomorphic adenoma of the salivary gland: Cytogenetic evidence of common origin of phenotypically diverse cells

      LABORATORY INVESTIGATION
    15. de Witte, T; Suciu, S; Verhoef, G; Labar, B; Archimbaud, E; Aul, C; Selleslag, D; Ferrant, A; Wijermans, P; Mandelli, F; Amadori, S; Jehn, U; Muus, P; Boogaerts, M; Zittoun, R; Gratwohl, A; Zwierzina, H; Hagemeijer, A; Willemze, R
      Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS

      BLOOD
    16. Franke, S; Wlodarska, I; Maes, B; Vandenberghe, P; Delabie, J; Hagemeijer, A; De Wolf-Peeters, C
      Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances

      BLOOD
    17. Michaux, L; Wlodarska, I; Stul, M; Dierlamm, J; Mugneret, F; Herens, C; Beverloo, B; Verhest, A; Verellen-Dumoulin, C; Verhoef, G; Selleslag, M; Madoe, V; Lecomte, M; Deprijck, B; Ferrant, A; Delannoy, A; Marichal, S; Duhem, C; Dicato, M; Hagemeijer, A
      MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23

      GENES CHROMOSOMES & CANCER
    18. von Bergh, A; Emanuel, B; van Zelderen-Bhola, S; Smetsers, T; van Soest, R; Stul, M; Vranckx, H; Schuuring, E; Hagemeijer, A; Kluin, P
      A DNA probe combination for improved detection of MLL/11q23 breakpoints bydouble-color interphase-FISH in acute leukemias

      GENES CHROMOSOMES & CANCER
    19. Ameye, G; Jacquy, C; Zenebergh, A; Stul, M; Vaerman, JL; Bilhou-Nabera, C; Libouton, JM; Deneys, V; Martiat, P; Hagemeijer, A; Cornu, G; Verellen-Dumoulin, C; Michaux, L
      The value of interphase fluorescence in situ hybridization for the detection of translocation t(12;21) in childhood acute lymphoblastic leukemia

      ANNALS OF HEMATOLOGY
    20. Mancini, M; Cedrone, M; Diverio, D; Emanuel, B; Stul, M; Vranckx, H; Brama, M; De Cuia, MR; Nanni, M; Fazi, F; Mecucci, C; Alimena, G; Hagemeijer, A
      Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients

      LEUKEMIA
    21. Dierlamm, J; Wlodarska, I; Michaux, L; Stefanova, M; Hinz, K; Van den Berghe, H; Hagemeijer, A; Hossfeld, DK
      Genetic abnormalities in marginal zone B-cell lymphoma

      HEMATOLOGICAL ONCOLOGY
    22. Janssen, JJWM; van Rijn, RS; van der Holt, B; Schuurhuis, GJ; Vellenga, E; Verhoef, GEG; Ossenkoppele, GJ; van den Berg, E; Hagemeijer, A; Slater, R; Nieuwint, AWM; Cornelissen, JJ
      Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests

      BONE MARROW TRANSPLANTATION
    23. Debiec-Rychter, M; Sciot, R; Hagemeijer, A
      Common chromosome aberrations in the proximal type of epithelioid sarcoma

      CANCER GENETICS AND CYTOGENETICS
    24. Debiec-Rychter, M; Hagemeijer, A; Sciot, R
      Cytogenetic analysis in three cerebral subependymomas: further evidence for a hamartomatous nature?

      CANCER GENETICS AND CYTOGENETICS
    25. Dierlamm, J; Stefanova, M; Wlodarska, I; Hinz, K; Maes, B; Michaux, L; Stul, M; Verhoef, G; Thomas, J; De Wolf-Peeters, C; Van den Berghe, H; Hossfeld, HK; Hagemeijer, A
      Analysis of-the P53, RB/D13S25, and P16 tumor suppressor genes in marginalzone B-cell lymphoma: An interphase fluorescence in situ hybridization study

      CANCER GENETICS AND CYTOGENETICS
    26. Dierlamm, J; Baens, M; Stefanova-Ouzounova, M; Hinz, K; Wlodarska, I; Maes, B; Steyls, A; Driessen, A; Verhoef, G; Gaulard, P; Hagemeijer, A; Hossfeld, DK; De Wof-Peeters, C; Marynen, P
      Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes

      BLOOD
    27. Sainty, D; Liso, V; Cantu-Rajnoldi, A; Head, D; Mozziconacci, MJ; Arnoulet, C; Benattar, L; Fenu, S; Mancini, M; Duchayne, E; Mahon, FX; Gutierrez, N; Birg, F; Biondi, A; Grimwade, D; Lafage-Pochitaloff, M; Hagemeijer, A; Flandrin, G
      A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

      BLOOD
    28. Grimwade, D; Biondi, A; Mozziconacci, MJ; Hagemeijer, A; Berger, R; Neat, M; Howe, K; Dastugue, N; Jansen, J; Radford-Weiss, I; Lo Coco, F; Lessard, M; Hernandez, JM; Delabesse, E; Head, D; Liso, V; Sainty, D; Flandrin, G; Solomon, E; Birg, F; Lafage-Pochitaloff, M
      Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party

      BLOOD
    29. Dierlamm, J; Wlodarska, I; Michaux, L; Stefanova, M; Seeger, D; Hinz, K; Hagemeijer, A; Hossfeld, DK
      Fluorescence in situ hybridization (FISH): A powerful method for the detection of genetic abnormalities in metaphases and in interphase nuclei

      INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    30. van der Reijden, BA; Dauwerse, HG; Giles, RH; Jagmohan-Changur, S; Wijmenga, C; Liu, PP; Smit, B; Wessels, HW; Beverstock, GC; Jotterand-Bellomo, M; Martinet, D; Muhlematter, D; Lafage-Pochitaloff, M; Gabert, J; Reiffers, J; Bilhou-Nabera, C; van Ommen, GJB; Hagemeijer, A; Breuning, MH
      Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered

      ONCOGENE
    31. Maes, B; Meeus, P; Michaux, L; Bijnens, L; Boogaerts, M; Hagemeijer, A; De Wolf-Peeters, C; Verhoef, G
      Application of the international Prognostic Scoring System for myelodysplastic syndromes

      ANNALS OF ONCOLOGY
    32. Baens, M; Wlodarska, I; Corveleyn, A; Hoornaert, I; Hagemeijer, A; Marynen, P
      A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: Hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p)

      GENOMICS
    33. Wlodarska, I; Pittaluga, S; Hagemeijer, A; De Wolf-Peeters, C; Van den Berghe, H
      Secondary chromosome changes in mantle cell lymphoma

      HAEMATOLOGICA
    34. Van den Berghe, I; Dal Cin, P; Sciot, R; Vanvuchelen, J; Michielssen, P; Hagemeijer, A; De Baene, L; Van den Berghe, H
      Translocation (4;8) as a primary chromosome change in a hydropic leiomyoma

      HISTOPATHOLOGY
    35. Dal Cin, P; Bertoni, F; Bacchini, P; Hagemeijer, A; Van den Berghe, H
      Fibrous dysplasia and the short arm of chromosome 12

      HISTOPATHOLOGY
    36. Konig, JJ; Teubel, W; van Steenbrugge, GJ; Romijn, JC; Hagemeijer, A
      Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines

      UROLOGICAL RESEARCH
    37. Sciot, R; Dal Cin, P; Hagemeijer, A; De Smet, L; Van Damme, B; Van den Berghe, H
      Cutaneous sclerosing perineurioma with cryptic NF2 gene deletion

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    38. Dawson, L; Slater, R; Hagemeijer, A; Langerak, AW; Willemze, R; Kluin-Nelemans, JC
      Secondary T-acute lymphoblastic leukaemia mimicking blast crisis in chronic myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    39. Van Den Neste, E; Louviaux, I; Michaux, JL; Delannoy, A; Michaux, L; Hagemeijer, A; Scheiff, JM; Bosly, A; Straetmans, N; Ferrant, A
      Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2 '-deoxyadenosine

      BRITISH JOURNAL OF HAEMATOLOGY
    40. Cools, J; Bilhou-Nabera, C; Wlodarska, I; Cabrol, C; Talmant, P; Bernard, P; Hagemeijer, A; Marynen, P
      Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12) (q11-q12;p13)

      BLOOD
    41. Fioretos, T; Strombeck, B; Sandberg, T; Johansson, B; Billstrom, R; Borg, A; Nilsson, PG; Van Den Berghe, H; Hagemeijer, A; Mitelman, F; Hoglund, M
      Isochromosome 17q in blast crisis of chronic myeloid leukemia and in otherhematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations

      BLOOD
    42. Cuneo, A; Bigoni, R; Rigolin, GM; Roberti, MG; Bardi, A; Piva, N; Milani, R; Bullrich, F; Veronese, ML; Croce, C; Birg, F; Dohner, H; Hagemeijer, A; Castoldi, G
      Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features

      BLOOD
    43. Dierlamm, J; Baens, M; Wlodarska, I; Stefanova-Ouzounova, M; Hernandez, JM; Hossfeld, DK; De Wolf-Peeters, C; Hagemeijer, A; Van den Berghe, H; Marynen, P
      The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas

      BLOOD
    44. Cuneo, A; Mecucci, C; Hagemeijer, A
      Cytogenetic and molecular abnormalities in myeloid malignancies

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    45. DIERLAMM J; STUL M; VRANCKX H; MICHAUX L; WEGHUIS DEMO; SPELEMAN F; SELLESLAG D; KRAMER MHH; NOENS LA; CASSIMAN JJ; VANDENBERGHE H; HAGEMEIJER A
      FISH IDENTIFIES INV(16)(P13Q22) MASKED BY TRANSLOCATIONS IN 3 CASES OF ACUTE MYELOID-LEUKEMIA

      Genes, chromosomes & cancer
    46. HAGEMEIJER A; CUNEO A; BIGONI R; WYSMAN J; SMIT B; CEDRONE M; EMANUEL B
      INTERPHASE FISH FOR DETECTION OF SPECIFIC CYTOGENETIC TRANSLOCATIONS IN HEMATOLOGICAL MALIGNANCIES - EVALUATION OF METHOD FOR DIAGNOSTIC AND FOLLOW-UP PURPOSES

      European journal of human genetics
    47. DAUWERSE H; VANDERRELJDEN B; SMIT B; BEVERSTOCK G; VANOMMEN GJ; HAGEMEIJER A; BREUNING M
      NEW PROBES FOR 2 COLOR FISH DETECTION OF INV(16) (P13Q22) IN AML M4EO

      European journal of human genetics
    48. CHAFFANET M; POPOVICI C; LEROUX D; JACROT M; ADELAIDE J; DASTUGUE N; GREGOIRE MJ; HAGEMEIJER A; LAFAGEPOCHITALOFF M; BIRNBAUM D; PEBUSQUE MJ
      T(6-8), T(8-9) AND T(8-13) TRANSLOCATIONS ASSOCIATED WITH STEM-CELL MYELOPROLIFERATIVE DISORDERS HAVE CLOSE OR IDENTICAL BREAKPOINTS IN CHROMOSOME REGION 8P11-12

      Oncogene
    49. Losi, L; Polito, P; Hagemeijer, A; Buonamici, L; Van den Berghe, H; Dal Cin, P
      Intracranial germ cell tumour (embryonal carcinoma with teratoma) with complex karyotype including isochromosome 12p

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    50. MICHAUX L; DIERLAMM J; WLODARSKA I; CRIEL A; LOUWAGIE A; FERRANT A; HAGEMEIJER A; VANDENBERGHE H
      TRISOMY 3Q11-Q29 IS RECURRENTLY OBSERVED IN B-CELL NON-HODGKINS-LYMPHOMAS ASSOCIATED WITH COLD AGGLUTININ SYNDROME

      Annals of hematology
    51. Van de Ven, WJM; Van den Berghe, H; Buys, C; Castedo, S; Dal Cin, P; della Porta, G; Dutrillaux, B; Hagemeijer, A; Mitelman, F; Turc-Carel, C; Young, B; Zang, K
      Molecular cytogenetics of solid tumours

      CANCER RESEARCH SUPPORTED UNDER BIOMED I
    52. MOORMAN AV; HAGEMEIJER A; CHARRIN C; RIEDER H; SECKERWALKER LM
      THE TRANSLOCATIONS, T(11-19)(Q23-P13.1) AND T(11-19)(Q23-P13.3) - A CYTOGENETIC AND CLINICAL PROFILE OF 53 PATIENTS

      Leukemia
    53. CUNEO A; BIGONI R; EMMANUEL B; SMIT E; RIGOLIN GM; ROBERTI MG; BARDI A; PIVA N; SCAPOLI G; CASTOLDI G; VANDENBERGHE H; HAGEMEIJER A
      FLUORESCENCE IN-SITU HYBRIDIZATION FOR THE DETECTION AND MONITORING OF THE PH-POSITIVE CLONE IN CHRONIC MYELOGENOUS LEUKEMIA - COMPARISON WITH METAPHASE BANDING ANALYSIS

      Leukemia
    54. HAGEMEIJER A; DEKLEIN A; WIJSMAN J; VANMEERTEN E; DEGREEF GE; SACCHI N
      DEVELOPMENT OF AN INTERPHASE FLUORESCENT IN-SITU HYBRIDIZATION (FISH)TEST TO DETECT T(8-21) IN AML PATIENTS

      Leukemia
    55. LOWENBERG B; SUCIU S; ARCHIMBAUD E; HAAK H; STRYCKMANS P; DECATALDO R; DEKKER AW; BERNEMAN ZN; THYSS A; VANDERLELIE J; SONNEVELD P; VISANI G; FILLET G; HAYAT M; HAGEMEIJER A; SOLBU G; ZITTOUN R
      MITOXANTRONE VERSUS DAUNORUBICIN IN INDUCTION-CONSOLIDATION CHEMOTHERAPY - THE VALUE OF LOW-DOSE CYTARABINE FOR MAINTENANCE OF REMISSION, AND AN ASSESSMENT OF PROGNOSTIC FACTORS IN ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - FINAL REPORT OF THE LEUKEMIA COOPERATIVE GROUP OF THE ANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER AND THE DUTCH-BELGIAN HEMATOONCOLOGY COOPERATIVE HOVON GROUP RANDOMIZED PHASE-III STUDY AML-9

      Journal of clinical oncology
    56. KONIG JJ; TEUBEL W; KAMST E; ROMIJN JC; SCHRODER FH; HAGEMEIJER A
      CYTOGENETIC ANALYSIS OF 39 PROSTATE CARCINOMAS AND EVALUATION OF SHORT-TERM TISSUE-CULTURE TECHNIQUES

      Cancer genetics and cytogenetics
    57. CORNELISSEN JJ; PLOEMACHER RE; WOGNUM BW; BORSBOOM A; KLUINNELEMANS HC; HAGEMEIJER A; LOWENBERG B
      AN IN-VITRO MODEL FOR CYTOGENETIC CONVERSION IN CML - INTERFERON-ALPHA PREFERENTIALLY INHIBITS THE OUTGROWTH OF MALIGNANT STEM-CELLS PRESERVED IN LONG-TERM CULTURE

      The Journal of clinical investigation
    58. PRINS JB; WILLIAMSON KA; KAMP MMK; VANHEZIK EJ; VANDERKWAST TH; HAGEMEIJER A; VERSNEL MA
      THE GENE FOR THE CYCLIN-DEPENDENT-KINASE-4 INHIBITOR, CDKN2A, IS PREFERENTIALLY DELETED IN MALIGNANT MESOTHELIOMA

      International journal of cancer
    59. MOZZICONACCI MJ; SAINTY D; GABERT J; ARNOULET C; SIMONETTI J; TOIRON Y; COSTELLO R; HAGEMEIJER A; LAFAGEPOCHITALOFF M
      THE PHILADELPHIA-CHROMOSOME AS A SECONDARY ABNORMALITY IN 2 CASES OF ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    60. CEDRONE M; MANCINI W; NANNI M; DECUIA MR; PETIT MC; BOSLY A; MICHAUX JL; SELLESLAG D; BRAMA M; ANGELOZZI AL; MECUCCI C; ALIMENA G; HAGEMEIJER A
      USE OF DUAL-COLOR INTERPHASE-FISH TECHNIQUE AT DIAGNOSIS, AT RELAPSE AND DURING THE FOLLOW-UP OF INV(16) AML PATIENTS

      British Journal of Haematology
    61. AMEYE G; JACQUY C; ZENEBERGH A; LIBOUTON JM; MARTIAT P; HAGEMEIJER A; CORNU G; VERELLENDUMOULIN C; MICHAUX L
      DUAL-COLOR INTERPHASE FISH COMPARED TO RT-PCR AND SOUTHERN BLOT FOR THE DETECTION OF T(12-21) IN CHILDHOOD ALL

      British Journal of Haematology
    62. DIERLAMM J; MICHAUX L; WEH HJ; WLODARSKA I; STEFANOVA M; STUL M; FERRANT A; CASSIMAN JJ; HAGEMEIJER A; VANDENBERGHE H; HOSSFELD DK
      BURKITTS LYMPHOMA-ASSOCIATED TRANSLOCATIONS IN MULTIPLE-MYELOMA AND PLASMA-CELL LEUKEMIA

      British Journal of Haematology
    63. STRAETMANS N; HERMAN P; VANBOCKSTAELE DR; MICHAUX L; HAGEMEIJER A; FERRANT A
      HEMATOPOIETIC DEFECT AND DECREASED EXPANSION POTENTIAL OF BONE-MARROWAUTOGRAFTS FROM PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION

      British Journal of Haematology
    64. WLODARSKA I; DEWOLFPEETERS C; FALINI B; VERHOEF G; MORRIS SW; HAGEMEIJER A; VANDENBERGHE H
      THE CRYPTIC INV(2)(P23Q35) DEFINES A NEW MOLECULAR-GENETIC SUBTYPE OFALK-POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA

      Blood
    65. WLODARSKA I; LASTARZA R; BAENS M; DIERLAMM J; UYTTEBROECK A; SELLESLAG D; FRANCINE A; MECUCCI C; HAGEMEIJER A; VANDENBERGHE H; MARYNEN P
      FLUORESCENCE IN-SITU HYBRIDIZATION CHARACTERIZATION OF NEW TRANSLOCATIONS INVOLVING TEL (ETV6) IN A WIDE SPECTRUM OF HEMATOLOGIC MALIGNANCIES

      Blood
    66. DIERLAMM J; WLODARSKA I; MICHAUX L; VERMEESCH JR; MEEUS P; STUL M; CRIEL A; VERHOEF G; THOMAS J; DELANNOY A; LOUWAGIE A; CASSIMAN JJ; MECUCCI C; HAGEMEIJER A; VANDENBERGHE H
      FISH IDENTIFIES DIFFERENT TYPES OF DUPLICATIONS WITH 12Q13-15 AS THE COMMONLY INVOLVED SEGMENT IN B-CELL LYMPHOPROLIFERATIVE MALIGNANCIES CHARACTERIZED BY PARTIAL TRISOMY-12

      Genes, chromosomes & cancer
    67. DIERLAMM J; ROSENBERG C; STUL M; PITTALUGA S; WLODARSKA I; MICHAUX L; DEHAEN M; VERHOEF G; THOMAS J; DEKELVER W; BAKKERSCHUT T; CASSIMAN JJ; RAAP AK; DEWOLFPEETERS C; VANDENBERGHE H; HAGEMEIJER A
      CHARACTERISTIC PATTERN OF CHROMOSOMAL GAINS AND LOSSES IN MARGINAL ZONE B-CELL LYMPHOMA DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION

      Leukemia
    68. VANLOM K; HAGEMEIJER A; VANDEKERCKHOVE F; DEGREEF GE; SACCHI N; LOWENBERG B
      CLONALITY ANALYSIS OF HEMATOPOIETIC-CELL LINEAGES IN ACUTE MYELOID-LEUKEMIA AND TRANSLOCATION-(8-21) - ONLY MYELOID CELLS ARE PART OF THE MALIGNANT CLONE

      Leukemia
    69. FERNHOUT F; DINKELAAR RB; HAGEMEIJER A; GROENEVELD K; VANKAMMEN E; VANDONGEN JJM
      4 AGED SIBLINGS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia
    70. GILES RH; DAUWERSE JG; HIGGINS C; PETRIJ F; WESSELS JW; BEVERSTOCK GC; DOHNER H; JOTTERANDBELLOMO M; FALKENBURG JHF; SLATER RM; VANOMMEN GJB; HAGEMEIJER A; VANDERREIJDEN BA; BREUNING MH
      DETECTION OF CBP REARRANGEMENTS IN ACUTE MYELOGENOUS LEUKEMIA WITH T(8-16)

      Leukemia
    71. CORNELISSEN JJ; WOGNUM AW; PLOEMACHER RE; FRASSONI F; WAGEMAKER G; HAGEMEIJER A; LOWENBERG B
      EFFICIENT LONG-TERM MAINTENANCE OF CHRONIC MYELOID LEUKEMIC COBBLESTONE AREA FORMING CELLS ON A MURINE STROMAL CELL-LINE

      Leukemia
    72. HAGEMEIJER A; DIERLAMM J; WLODARSKA I; SMIT E
      FISH IN HEMATOLOGICAL MALIGNANCIES - A TOOL FOR CYTOGENETIC DIAGNOSISAND RESEARCH

      Cytogenetics and cell genetics
    73. BIGONI R; CUNEO A; ROBERTI MG; BARDI A; SCAPOLI GL; HAGEMEIJER A; CASTOLDI GL
      DETECTION AND MONITORING OF PH-POSITIVE CELLS IN CHRONIC MYELOGENOUS LEUKEMIA UNDER INTERFERON THERAPY BY INTERPHASE CYTOGENETICS - COMPARISON WITH CONVENTIONAL CHROMOSOME ANALYSIS

      Cytogenetics and cell genetics
    74. WEIJERMAN PC; VANDRUNEN E; KONIG JJ; TEUBEL W; ROMIJN JC; SCHRODER FH; HAGEMEIJER A
      SPECIFIC CYTOGENETIC ABERRATIONS IN 2 NOVEL HUMAN PROSTATIC CELL-LINES IMMORTALIZED BY HUMAN-PAPILLOMAVIRUS TYPE-18 DNA

      Cancer genetics and cytogenetics
    75. LASTARZA R; MATTEUCCI C; CRESCENZI B; PERLA G; CAROTENUTO M; MARTELLI MF; HAGEMEIJER A; MECUCCI C
      IDENTIFICATION OF CHROMOSOME CHANGES IN ACUTE MYELOID-LEUKEMIA (AML-M2) BY MOLECULAR CYTOGENETICS

      Cancer genetics and cytogenetics
    76. MICHAUX L; DIERLAMM J; WLODARSKA I; BOURS V; VANDENBERGHE H; HAGEMEIJER A
      T(14-19) BCL3 REARRANGEMENTS IN LYMPHOPROLIFERATIVE DISORDERS - A REVIEW OF 23 CASES/

      Cancer genetics and cytogenetics
    77. PEETERS P; WLODARSKA I; BAENS M; CRIEL A; SELLESLAG D; HAGEMEIJER A; VANDENBERGHE H; MARYNEN P
      FUSION OF ETV6 TO MDS1 EVI1 AS A RESULT OF T(3-12)(Q26-P13) IN MYELOPROLIFERATIVE DISORDERS/

      Cancer research
    78. DIERLAMM J; PITTALUGA S; STUL M; WLODARSKA I; MICHAUX L; THOMAS J; VERHOEF G; VERHEST A; DEPARDIEU C; CASSIMAN JJ; HAGEMEIJER A; DEWOLFPEETERS C; VANDENBERGHE H
      BCL6 GENE REARRANGEMENTS ALSO OCCUR IN MARGINAL ZONE B-CELL LYMPHOMA

      British Journal of Haematology
    79. DELANNOY A; LOUWAGIE AC; KLUINNELEMANS JC; VANDENBURGH JF; BOOGAERTS MA; BOSLY A; MICHAUX JL; ZACHEE P; HAGEMEIJER A; VANDENBERGHE H
      A RANDOMIZED STUDY ON HYDROXYUREA ALONE VERSUS HYDROXYUREA COMBINED WITH LOW-DOSE INTERFERON-ALPHA-2B FOR CHRONIC MYELOID-LEUKEMIA

      Blood
    80. DEGREEF GE; HAGEMEIJER A
      MOLECULAR AND CYTOGENETIC ABNORMALITIES IN ACUTE MYELOID-LEUKEMIA ANDMYELODYSPLASTIC SYNDROMES

      Bailliere's clinical haematology
    81. MCKAY MJ; TROELSTRA C; VANDERSPEK P; KANAAR R; SMIT B; HAGEMEIJER A; BOOTSMA D; HOEIJMAKERS JHJ
      SEQUENCE CONSERVATION OF THE RAD21 SCHIZOSACCHAROMYCES-POMBE DNA DOUBLE-STRAND BREAK REPAIR GENE IN HUMAN AND MOUSE

      Genomics
    82. VANDERSPEK PJ; VISSER CE; HANAOKA F; SMIT B; HAGEMEIJER A; BOOTSMA D; HOEIJMAKERS JHJ
      CLONING, COMPARATIVE MAPPING, AND RNA EXPRESSION OF THE MOUSE HOMOLOGS OF THE SACCHAROMYCES-CEREVISIAE NUCLEOTIDE EXCISION-REPAIR GENE RAD23

      Genomics
    83. VANDERREIJDEN BA; MARTINET D; DAUWERSE JG; GILES RH; WESSELS JW; BEVERSTOCK GC; SMIT B; MUHLEMATTER D; BELLOMO MJ; GABERT J; LAFAGEPOCHITALOFF M; REIFFERS J; BILHOUNABERA C; VANOMMEN GJB; HAGEMEIJER A; BREUNING MH
      SIMPLE METHOD FOR DETECTION OF MYH11 DNA REARRANGEMENTS IN PATIENTS WITH INV(16)(P13Q22) AND ACUTE MYELOID-LEUKEMIA

      Leukemia
    84. DYER MJS; LILLINGTON DM; BASTARD C; TILLY H; LENS D; HEWARD JM; STRANKS G; MORILLA R; MONARD S; GUGLIELMI P; KLUINNELEMANS JC; HAGEMEIJER A; YOUNG BD; CATOVSKY D
      CONCURRENT ACTIVATION OF MYC AND BCL2 IN B-CELL NON-HODGKIN-LYMPHOMA CELL-LINES BY TRANSLOCATION OF BOTH ONCOGENES TO THE SAME IMMUNOGLOBULIN HEAVY-CHAIN LOCUS

      Leukemia
    85. HAGEMEIJER A
      MONITORING OF RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA - METHODOLOGICAL APPROACHES AND CLINICAL ASPECTS - COMMENTS

      Leukemia
    86. VANDERREIJDEN BA; VANOMMEN GJB; HAGEMEIJER A; BREUNING MH
      ACUTE MYELOGENOUS LEUKEMIA - A DISORDER OF GENE-SPLICING

      Leukemia
    87. VANDEVEN W; HAGEMEIJER A; KUCHERLAPATI R; MARYNEN P
      REPORT OF THE INTERNATIONAL MEETING ON CHROMOSOME-12 GENES IN CANCER 1995

      Cytogenetics and cell genetics
    88. GILES RH; PETRIJ F; DAUWERSE JG; BEVERSTOCK GC; HAGEMEIJER A; PETERS DJM; BREUNING MH
      CONSTRUCTION OF A 850-KB COSMID CONTIG SURROUNDING THE CBP GENE, INVOLVED IN RUBINSTEIN-TAYBI SYNDROME AND ANLL M4 M5 WITH T(8-16)(P11-P13.3)/

      Cytogenetics and cell genetics
    89. MENKEPLUYMERS MBE; VANDRUNEN E; VISSERS KJ; MULDER AH; TILANUS HW; HAGEMEIJER A
      CYTOGENETIC ANALYSIS OF BARRETTS MUCOSA AND ADENOCARCINOMA OF THE DISTAL ESOPHAGUS AND CARDIA

      Cancer genetics and cytogenetics
    90. ARKESTEIJN GJA; ERPELINCK SLA; MARTENS ACM; HAGEMEIJER A; HAGENBEEK A
      THE USE OF FISH WITH CHROMOSOME-SPECIFIC REPETITIVE DNA PROBES FOR THE FOLLOW-UP OF LEUKEMIA PATIENTS - CORRELATIONS AND DISCREPANCIES WITHBONE-MARROW CYTOLOGY

      Cancer genetics and cytogenetics
    91. VANDENAKKER TW; RADL J; FRANKENPOSTMA E; HAGEMEIJER A
      CYTOGENETIC FINDINGS IN MOUSE MULTIPLE-MYELOMA AND WALDENSTROMS MACROGLOBULINEMIA

      Cancer genetics and cytogenetics
    92. KONIG JJ; TEUBEL W; ROMIJN JC; SCHRODER FH; HAGEMEIJER A
      GAIN AND LOSS OF CHROMOSOME-1, CHROMOSOME-7, CHROMOSOME-8, CHROMOSOME-10, CHROMOSOME-18, AND CHROMOSOME-Y IN 46 PROSTATE CANCERS

      Human pathology
    93. LUYTEN GPM; NAUS NC; MOOY CM; HAGEMEIJER A; KANMITCHELL J; VANDRUNEN E; VUZEVSKI V; DEJONG PTVM; LUIDER TM
      ESTABLISHMENT AND CHARACTERIZATION OF PRIMARY AND METASTATIC UVEAL MELANOMA CELL-LINES

      International journal of cancer
    94. MICHAUX L; DIERLAMM J; ZELLER W; DENEYS V; WLODARSKA I; SCHEIFF JM; CRIEL A; MEEUS P; MICHAUX JL; FERRANT A; SELLESLAG D; VERHOEF G; HERNANDEZ JM; VERELLENDUMOULIN C; VANDENBERGHE H; HAGEMEIJER A
      TRISOMY-13 IN MYELOID MALIGNANCIES - CLINICAL, MORPHOLOGIC AND IMMUNOLOGICAL CORRELATIONS AND CHARACTERIZATION BY COMBINED IMMUNOPHENOTYPING AND INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION (FISH)

      Blood
    95. CORNELISSEN JJ; PLOEMACHER RE; WOGNUM AW; KLUINNELEMANS JC; HAGEMEIJER A; LOWENBERG B
      INTERFERON-ALPHA PREFERENTIALLY INHIBITS THE IN-VITRO OUTGROWTH OF MALIGNANT AS COMPARED TO NORMAL STEM-CELLS FROM INDIVIDUAL CHRONIC MYELOID-LEUKEMIA PATIENTS WITH A MAJOR OR COMPLETE CYTOGENETIC RESPONSE IN-VIVO

      Blood
    96. VANDERREIJDEN BA; HAGEMEIJER A; BREUNING MH
      NOVEL CBFB-MYH11 FUSION TRANSCRIPTS OR REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ARTIFACTS

      Blood
    97. LANGERAK AW; WILLIAMSON KA; MIYAGAWA K; HAGEMEIJER A; VERSNEL MA; HASTIE ND
      EXPRESSION OF THE WILMS-TUMOR GENE-WT1 IN HUMAN-MALIGNANT MESOTHELIOMA CELL-LINES AND RELATIONSHIP TO PLATELET-DERIVED GROWTH FACTOR-A AND INSULIN-LIKE GROWTH FACTOR-2 EXPRESSION

      Genes, chromosomes & cancer
    98. BUIJS A; SHERR S; VANBAAL S; VANBEZOUW S; VANDERPLAS D; VANKESSEL AG; RIEGMAN P; DEPREZ RL; ZWARTHOFF E; HAGEMEIJER A; GROSVELD G
      TRANSLOCATION (12-22) (P13-Q11) IN MYELOPROLIFERATIVE DISORDERS RESULTS IN FUSION OF THE ETS-LIKE TEL GENE ON 12P13 TO THE MN1 GENE ON 22Q11

      Oncogene
    99. STEGMANN APA; HONDERS MW; HAGEMEIJER A; HOEBEE B; WILLEMZE R; LANDEGENT JE
      IN VITRO-INDUCED RESISTANCE TO THE DEOXYCYTIDINE ANALOGS CYTARABINE (ARAC) AND 5-AZA-2'-DEOXYCYTIDINE (DAC) IN A RAT MODEL FOR ACUTE MYELOID-LEUKEMIA IS MEDIATED BY MUTATIONS IN THE DEOXYCYTIDINE KINASE (DCK) GENE

      Annals of hematology
    100. ROLLER ML; LOSSIE AC; KOKEN MHM; SMIT EME; HAGEMEIJER A; CAMPER SA
      LOCALIZATION OF SEQUENCES RELATED TO THE HUMAN RAD6 DNA-REPAIR GENE ON MOUSE CHROMOSOME-11 AND CHROMOSOME-13

      Mammalian genome


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 11:18:33